BridgeMD
New treatment option for Diabetes Mellitus Type 2
Official title App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management
ClinicalTrials.gov ID: NCT06214520
What this study is testing
- What it's testing
- There is an urgent need for better control and prevention of complications in type 2 diabetes mellitus (T2DM). Behavioural change is critical, and while literature suggests that motivational interviewing (MI) may be effective in improving glycemic control, none has explored app-based MI designed specifically for T2DM.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 100
You may be able to join if
- Aged 21 years and above
- Have been diagnosed with diabetes (T2DM)
- Had HbA1c result of ≥ 7.5% within past 3 months
- Physically able to exercise
- Able to read and converse in English
You likely can't join if
- On bolus insulin treatment
- Require assistance with basic activities of daily living (BADL)
- Have planned major operation or surgical procedure within 9 months from the time of recruitment
- Cognitively impaired (scored \< 6 on the Abbreviated Mental Test)
- Currently pregnant or lactating
- Current participants of ongoing clinical trials involving the usage of a smartphone wearable tracker or mobile health app to assist diabetes...
See the full eligibility criteria
- Aged 21 years and above
- Have been diagnosed with diabetes (T2DM)
- Had HbA1c result of ≥ 7.5% within past 3 months
- Physically able to exercise
- Able to read and converse in English
- Able to download the Empower+ app, use the smartphone wearable tracker, and conform to the minimum smartwatch and app monitoring schedule
- On bolus insulin treatment
- Require assistance with basic activities of daily living (BADL)
- Have planned major operation or surgical procedure within 9 months from the time of recruitment
- Cognitively impaired (scored \< 6 on the Abbreviated Mental Test)
- Currently pregnant or lactating
- Current participants of ongoing clinical trials involving the usage of a smartphone wearable tracker or mobile health app to assist diabetes management
- Past Empower study participants who refused to participate in future Empower studies
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.